Advanced Search

 

Study ID Status Title Patient Level Data
SAS40067 Completed Gaining asthma control with Seretide 50/500 in patients with moderate to severe persistent asthma in general practice.
SAS40068 Completed A 24 week, multicentre, randomized, double-blind, parallel group trial to compare the efficacy and tolerability of salmeterol/fluticasone propionate (ADVAIR) DISKUS inhalation ...
SB020001 Completed A Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-Center Study of VENTOLIN™ (albuterol) HFA MDI delivered with facemask and two different holding chambers in Subjects aged 24 to <48 months with asthma symptoms (i.e. wheeze, cough, dyspnea or chest tightness) or consistent with asthma or obstructive airway disease or bronchospasm. Study Listed on ClinicalStudyDataRequest.com
SB030001 Completed A Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-Center Study of VENTOLIN™ HFA MDI delivered TID with facemask and valved holding chamber Aerochamber Plus in subjects birth to <24 months in age with symptoms of bronchospasm (i.e. wheeze, cough, dyspnea or chest tightness) consistent with obstructive airways disease. Study Listed on ClinicalStudyDataRequest.com
SB030002 Completed A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively with a valved holding chamber and an attached facemask in subjects between birth to 23 months of age with acute wheezing due to obstructive airways disease Study Listed on ClinicalStudyDataRequest.com
SB030003 Completed An Open-Label, Multi-Center Study to Evaluate the Performance and Patient Satisfaction of Albuterol HFA with Counter in Asthma or COPD Subjects at Least 4 Years of Age. Study Listed on ClinicalStudyDataRequest.com
SB29060.833 Completed An open label study assessing Paxil CR (paroxetine CR) in patients with major depressive disorder who discontinued treatment with selective serotonin reuptake inhibitors or a selective serotonin/norepinephrine reuptake inhibitor due to intolerability
SB-462795/008 Completed An open-label, two-period, fixed sequence, randomized, parallel group, interaction study to determine the effects of repeat doses of relacatib on the metabolism of acetaminophen, ibuprofen and atorvastatin in healthy postmenopausal female subjects
SB-480848/026 Completed An International, Multicenter, Randomized, Placebo-controlled, Parallel-group, 1 Year Treatment, Integrated Biomarkers and Imaging Study in Subjects with Angiographically Documented Coronary Heart Disease (CHD) to Examine the Effects of the Novel Lipoprotein-associated Phospholipase A2 (Lp-PLA2) inhibitor SB-480848 on Intermediate Cardiovascular Endpoints, Patient Safety and Tolerability Study Listed on ClinicalStudyDataRequest.com
SB681323/011 Completed An open label study to determine the excretion balance and pharmacokinetics of [14C]SB-681323, administered as a single dose of an oral solution to healthy adult male subjects.
SB-705498/008 Completed A single blind, placebo controlled, multi-centre study to investigate the pharmacokinetics, safety, tolerability and pharmacodynamics of the TRPV1 antagonist SB-705498 against the pain of acute migraine.
SB-714703/003 Completed An open, randomised, multi-centre dose ranging phase II study to evaluate LAPDAP in combination with three different doses of artesunate
SBM20001 Completed A single centre, randomised, double-blind, double-dummy, placebo-controlled, parallel group, pilot study to determine the efficacy and safety of 2mg and 4mg doses of Ventolin ™ (salbutamol) syrup for the treatment of cough associated with acute viral upper respiratory tract infection, during a 3 ...
SBM20002 Completed A single centre, randomised, double-blind, placebo-controlled, crossover, pilot study to determine the efficacy and safety of 400 µg and 200 µg doses of Ventolin ™ salbutamol inhaler versus placebo for the treatment of smoking related cough. Study Listed on ClinicalStudyDataRequest.com
SBM40003 Completed A single centre, randomised, double blind, double dummy, cross-over study to measure the topical and systemic effects of Salbutamol delivered by the Turbuhaler inhaler compared with the Diskus dry powder inhaler at high and low flow rates in adult patients with reversible obstructive airways disease. Study Listed on ClinicalStudyDataRequest.com
SCA100223 Completed A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose, 8-Week Evaluation of the Efficacy and Safety of Lamotrigine in the Treatment of Depression in Patients with Type II Bipolar Disorder Study Listed on ClinicalStudyDataRequest.com
SCA102833 Completed The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age Study Listed on ClinicalStudyDataRequest.com
SCA104753 Completed An Open-Label Extension Study to Assess the Safety of Lamotrigine in Subjects with Bipolar Disorder, who are in remission following a manic/hypomanic index episode or a depressive index episode.
SCA104779 Completed Study SCA104779, an evaluation of BW430C (lamotrigine) versus placebo in the prevention of mood episodes in bipolar I disorder patients Study Listed on ClinicalStudyDataRequest.com
SCA106052 Completed Study SCA106052, a clinical evaluation of BW430C (lamotrigine) in bipolar I disorder– Long-term extension study (extension of study SCA104779 (NCT00550407)) Study Listed on ClinicalStudyDataRequest.com
SCA10908 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and olanzapine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA10910 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and oxcarbazepine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA20022 Completed Title A Randomized, Multicenter, Double–Blind, Placebo–Controlled, Fixed–Dose, 7–Week Evaluation of the Efficacy and Safety of Lamotrigine in Patients with Major Depression
SCA20025 Completed A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose 7-Week Evaluation of theEfficacy and Safety of Lamotrigine in Treatment of a Major Depressive Episode in Unipolar DepressedPatients
SCA30905 Completed A mulitcentre, double-blind, randomised, fixed-dose evaluation of the safety and efficacy of Lamictal (lamotrigine) compared to placebo as an add-on therapy to lithium or another mood stabiliser in the treatment of bipolar depression, followed by long-term prevention of relapse and recurrence of depression and/or mania in patients with bipolar disorder

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.